Marihuana pp 93-109 | Cite as

Examination of the Metabolites of Δ1-Tetrahydrocannabinol in Mouse Liver, Heart, and Lung by Combined Gas Chromatography and Mass Spectrometry

  • D. J. Harvey
  • W. D. M. Paton
Conference paper

Abstract

The distribution of Δ1-tetrahydrocannabinol (Δ1-THC, I) in tissues has been widely studied by radiochemical methods, and substantial accumulations have been found in certain organs, notably liver, lung, spleen, kidney, and adrenal gland [1,18,19]. Nevertheless, comparatively little is known about the nature of the accumulated material, although it is apparent that both Δ1-THC and various metabolites are present. Differences in the relative concentrations of the metabolites in tissues, particularly lung and liver, have been recognized [16], suggesting biotransformation of Δ1-THC at several sites. Several of the reported hydroxylated metabolites, in particular 7-OH-Δ1-THC (II), possess pharmacological activity [9,11], and one metabolite, 1,2-epoxide (VII) [3,12], is potentially chemically active [10]. The structures of a number of metabolites are still unknown and could contribute to the overall activity of the drug (Table 9.1) [13].

Keywords

Cholesterol Vortex Chloroform Triglyceride Epoxide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Agurell, S., J. Dahmén, B. Gustafsson, V.-B. Johansson, K. Leander, I. Nilsson, J. L. G. Nilsson, M. Nordqvist, C. H. Ramsay, A. Ryrfeldt, F. Sandberg, M. Widman (1972) Metabolic fate of tetrahydrocannabinol. Cannabis and Its Derivatives: Pharmacology and Experimental Psychology (W. D. M. Paton and J. Crown, eds.). London: Oxford University Press, pp. 16–36.Google Scholar
  2. 2.
    Ben-Zvi, Z. and S. Burstein (1974) 7-Oxo-Δ1-tetrahydrocannabinol: a novel metabolite of Δ1-tetrahydrocannabinol. Res. Commun. Chem. Pathol. Pharmacol.8:223.PubMedGoogle Scholar
  3. 3.
    Ben-Zvi, Z. and S. Burstein (1975) Transformation of Δ1-tetra-hydrocannabinol (THC) by rabbit liver microsomes. Biochem. Pharmacol.24:1130.PubMedCrossRefGoogle Scholar
  4. 4.
    Biller, J. E. and K. Biemann (1974) Reconstructed mass spectra, a novel approach for the utilization of gas chromatograph-mass spectrometer data. Anal. Lett.7:515.CrossRefGoogle Scholar
  5. 5.
    Binder, M., S. Agurell, K. Leander, and J.-E. Lindgren (1974) Zur identification potentieller metabolite von cannabis-inhaltstoffen: kernresonanz- und massenspektroskopische Untersuchungen an seiten-kettenhydroxylierten cannabinoiden. Helv. Chim. Acta57:1626.PubMedCrossRefGoogle Scholar
  6. 6.
    Burstein, S. H. (1973) Labeling and metabolism of the tetrahydrocannabinols. Marijuana: Chemistry, Pharmacology, Metabolism and Clinical Effects (R. Mechoulam, ed.). New York: Academic Press, pp. 167–190.Google Scholar
  7. 7.
    Burstein, S. H., J. Martinez, J. Rosenfeld, and T. Wittstruck (1972) The urinary metabolites of Δ1-THC. Cannabis and Its Derivatives (W. D. M. Paton and J. Crown, eds.). London: Oxford University Press, pp. 39–49.Google Scholar
  8. 8.
    Burstein, S. H., J. Rosenfeld, and T. Wittstruck (1972) Isolation and characterization of two major urinary metabolites of delta (1)-tetrahydrocannabinol. Science176:422.PubMedCrossRefGoogle Scholar
  9. 9.
    Christensen, H. D., R. I. Freudenthal, J. T. Gidley, R. Rosenfeld, G. Boegli, L. Testino, D. R. Brine, C. G. Pitt, and M. E. Wall (1971) Activity of Δ8- and Δ9-tetrahydrocannabinol and related compounds in the mouse. Science172:165.PubMedCrossRefGoogle Scholar
  10. 10.
    Daly, J. W., D. M. Jerina, and B. Witkop (1972) Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia28:1129.PubMedCrossRefGoogle Scholar
  11. 11.
    Gill, E. W., G. Jones, and D. K. Lawrence (1973) Contribution of the metabolite 7-hydroxy-Δ1-tetrahydrocannabinol towards the pharmacological activity of Δ1-tetrahydrocannabinol in mice. Biochem. Pharmacol.22:175.PubMedCrossRefGoogle Scholar
  12. 12.
    Gurny, O., D. E. Maynard, R. G. Pitcher, and R. W. Kierstead (1972) Metabolism of (-)-Δ9 and (-)-Δ8-tetrahydrocannabinol by monkey liver. J. Am. Chem. Soc.94:7928.PubMedCrossRefGoogle Scholar
  13. 13.
    Jones, G., M. Widman, S. Agurell, and J.-E. Lindgren (1974) Monohydroxylated metabolites of Δ1-tetrahydrocannabinol in mouse brain. Acta Pharm. Suec.11:283.PubMedGoogle Scholar
  14. 14.
    Maynard, D. E., O. Gurny, R. G. Pitcher, and R. W. Kierstead (1971) (-)-Δ8-Tetrahydrocannabinol. Two novel in vitro metabolites. Experientia27:1154.PubMedCrossRefGoogle Scholar
  15. 15.
    McCloskey, J. A., R. N. Stillwell, and A. M. Lawson (1968) Use of deuterium-labeled trimethylsilyl derivatives in mass spectrometry. Anal. Chem.40:233.CrossRefGoogle Scholar
  16. 16.
    Nakazawa, K. and E. Costa (1971) Metabolism of Δ9-tetrahydro-cannabinol by lung and liver homogenates of rats treated with methylcholanthrene. Nature234:48.PubMedCrossRefGoogle Scholar
  17. 17.
    Nordqvist, M., S. Agurell, M. Binder, and I. M. Nilsson (1974) Structure of an acidic metabolite of Δ1-tetrahydrocannabinol isolated from rabbit urine. J. Pharm. Pharmacol.26:471.PubMedCrossRefGoogle Scholar
  18. 18.
    Ryrfeldt, Å., C H. Ramsay, I. M. Nilsson, M. Widman, and S. Agurell (1973) Whole-body autoradiography of Δ1-tetrahydrocannabinol and Δ1(6)-tetrahydrocannabinol in mouse. Pharmacokinetic aspects of Δ1-tetrahydrocannabinol and its metabolites. Acta Pharm. Suec.10:13.PubMedGoogle Scholar
  19. 19.
    Truitt, E. B., Jr. and M. Braude (1974) Research Advances in Alcohol and Drug Problems (R. J. Gibbins, Y. Israel, H. Kalant, R. E. Popham, W. Schmidt, and R. G. Smart, eds.), vol. 1. New York: Wiley, p. 199.Google Scholar
  20. 20.
    Wall, M. E. (1971) The in vitro and in vivo metabolism of tetrahydrocannabinol (THC). Ann. N.Y. Acad. Sci.191:23.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1976

Authors and Affiliations

  • D. J. Harvey
  • W. D. M. Paton

There are no affiliations available

Personalised recommendations